Citation Impact
Citing Papers
Mechanisms of Viral Membrane Fusion and Its Inhibition
2001
Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy
2012 StandoutScienceNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Identification of a major co-receptor for primary isolates of HIV-1
1996 StandoutNature
The role of CD4 in HIV binding and entry
1993
A role for CD95 ligand in preventing graft rejection
1995 StandoutNature
Three-dimensional solution structure of the 44kDa ectodomain of SIV gp41
1998
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
2001 StandoutNature
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
2006
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution
1998 StandoutNature
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
1998 StandoutNature
Structure of an unliganded simian immunodeficiency virus gp120 core
2005 Nature
Modifications of CD8+ T Cell Function during In Vivo Memory or Tolerance Induction
1998
Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its c-DNA
1990
SNAREpins: Minimal Machinery for Membrane Fusion
1998 StandoutNobel
Core Structure of gp41 from the HIV Envelope Glycoprotein
1997 Standout
Cancer immunoediting from immune surveillance to immune escape
2007
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
1998 StandoutNobel
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
The C-Terminal Domain of TolA Is the Coreceptor for Filamentous Phage Infection of E. coli
1997
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
1994 StandoutScience
Membrane Fusion
2003 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Super-resolution biomolecular crystallography with low-resolution data
2010 StandoutNatureNobel
Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones
1995
Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15
2007
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Type I Interferons Potently Enhance Humoral Immunity and Can Promote Isotype Switching by Stimulating Dendritic Cells In Vivo
2001
Interferon signalling network in innate defence
2006
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
HIV as the cause of AIDS
1996 StandoutNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
The Fas Death Factor
1995 StandoutScience
The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection
1995
Molecular characterization of mitochondrial apoptosis-inducing factor
1999 StandoutNature
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
1998 StandoutNature
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
1997 StandoutNatureNobel
Inhibition of death receptor signals by cellular FLIP
1997 StandoutNature
Role of interferons in the regulation of cell proliferation, differentiation, and development
1994
HIV-1: Cofactors provide the entry keys
1996
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Analysis of the MCMV resistome by ENU mutagenesis
2006 StandoutNobel
Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.
1996 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.
1995
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
1996
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
2011 StandoutScienceNobel
Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex.
1994
Proteasome regulation of activation-induced T cell death
1997 StandoutNobel
Novel folded protein domains generated by combinatorial shuffling of polypeptide segments
2000 StandoutNobel
Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function
2009 StandoutNobel
Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway.
1996
STATs and Gene Regulation
1997 StandoutScience
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1
1994
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
1995 Standout
Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides
1998
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions
2001
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Reversible silencing of enhancers by sequences derived from the human IFN-α promoter
1987
Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice
1996 Science
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1
1997
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
2000 StandoutScienceNobel
The Yin and Yang of T Cell Costimulation
1995 StandoutScienceNobel
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
1998 StandoutNobel
The Membrane-Proximal Tryptophan-Rich Region of the HIV Glycoprotein, gp41, Forms a Well-Defined Helix in Dodecylphosphocholine Micelles,
2001
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus
2006 StandoutNobel
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.
1995
Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway.
1989
Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding
1995
Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice
2002 StandoutNobel
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
1989 StandoutScience
HIV replication in CD4+T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines
1996 StandoutNobel
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies
1994
GP120: Biologic Aspects of Structural Features
2001
Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26
1994
Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions
1999
Increased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus Variants
2001
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Mechanisms and Genes of Cellular Suicide
1995 StandoutScience
Apoptosis by a cytosolic extract from Fas-activated cells.
1995
Adenovirus-mediated gene delivery and in vitro microinsemination produce offspring from infertile male mice
2002 StandoutNobel
Works of F Vignaux being referenced
TCR/CD3 coupling to Fas-based cytotoxicity.
1995
Interferon messenger RNA is produced constitutively in the organs of normal individuals.
1987
Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding
1993
Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus.
1984
Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop
1993
Binding of 125I‐labelled human αinterferon to human lymphoid cells
1981
Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.
1988